TABLE 3

Biodistribution of 67Ga-IMP 241 Given Alone, with No bsAb Pretargeting

TissueTime after injection of 67Ga-IMP 241 peptide
1 h2 h3 h4 h6 h
Tumor0.7 ± 0.40.3 ± 0.10.2 ± 0.10.2 ± 0.00.1 ± 0.0
Liver0.1 ± 0.00.1 ± 0.00.1 ± 0.00.1 ± 0.00.1 ± 0.0
Spleen0.0 ± 0.00.1 ± 0.10.1 ± 0.00.1 ± 0.00.1 ± 0.0
Kidney2.2 ± 0.81.7 ± 0.52.6 ± 0.72.0 ± 0.42.6 ± 0.5
Lungs0.1 ± 0.10.1 ± 0.10.1 ± 0.00.0 ± 0.00.1 ± 0.0
Blood0.1 ± 0.00.1 ± 0.00.0 ± 0.00.0 ± 0.00.0 ± 0.0
Stomach0.1 ± 0.10.0 ± 0.00.0 ± 0.00.1 ± 0.10.0 ± 0.0
Small intestine0.3 ± 0.30.1 ± 0.10.1 ± 0.10.3 ± 0.20.0 ± 0.0
Large intestine0.1 ± 0.00.0 ± 0.00.0 ± 0.00.5 ± 0.80.1 ± 0.0
Bone0.1 ± 0.10.1 ± 0.00.1 ± 0.00.1 ± 0.00.0 ± 0.0
  • Data are expressed as percentage injected dose per gram (%ID/g) of tissue ± SD (5 animals per group).